Biomarkers in various types of atrophic gastritis and their diagnostic usefulness

Digestive Diseases and Sciences

Volumn 50, Issue 3, 2005, Pages 474-482

  Rembiasz, Kazimierz ^a   Konturek, Peter C ^a   Karcz, Danuta ^a   Konturek, Stanislaw J ^a   Ochmanski, Władysław ^a   Bielanski, Wladyslaw ^a   Budzynski, Andrzej ^a   Stachura, Jerzy ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antibodies against oxyntic cells; Atrophic gastritis; Gastrin; H. pylori; Pepsinogen I

Indexed keywords

BIOLOGICAL MARKER; GASTRIN; PENTAGASTRIN; PEPSINOGEN I;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; GASTRIN BLOOD LEVEL; GASTROINTESTINAL ENDOSCOPY; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; SEROLOGY; STATISTICAL SIGNIFICANCE; STOMACH ACID SECRETION; STOMACH ANTRUM; STOMACH BIOPSY; UREA BREATH TEST;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PEPSINOGEN A; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 17444370506     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2461-8     Document Type: Article

References (41)

1. Strickland RG,Mackay IR: A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 18:426-440, 1973
2. Correa P: The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res 6:98-108, 1980
3. Wyatt JI, Dixon MF: Chronic gastritis - A pathogenetic approach. J Pathol 154:113-124, 1988
4. Stolte M, Heilmann KL: Neue Klassifikation und Graduierung der Gastritis. Leber Magen Darm 19:220-226, 1989
5. Price AB: The Sydney system: Histological division. J Gastroenterol Hepatol 6:209-222, 1991
6. Sipponen P, Kekki M, Siurala M: The Sydney System: Epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 6:244-251, 1991
7. Dixon MF, Genta RM, Yardley JH, Correa P, participants in the International Workshop on the Histopathology of Gastritis, Houston 1994: Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 20:1161-1181, 1996
8. Correa P: Chronic gastritis: A clinico-pathological classification. Am J Gastroenterol 83:504-509, 1988.
9. Yardley JH, Hendrix TR: Gastritis, duodenitis and associated ulcerative lesions. In: Yamada T (ed) Textbook of Gastroenterology, Philadelphia, JB Lippincott, 1995
10. Craannen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN: Subtypes of intestinal metaplasia and Helicobacter pylori. Gut 33:597-600, 1992
11. Genta RM: Recognizing atrophy: Another step toward a classification of gastritis. Am J Surg Pathol 20:S23-S30, 1996
12. Hughes SF, Winslet MC: Premalignant lesion of the stomach. Part I: Atrophic gastritis and gastric atrophy. Part II: Intestinal metaplasia. GI Cancer 3:157-180, 2000
13. Morson B, Dawson I: Gastritis In: Morson & Dawson's Gastrointestinal Pathology. London, Blackwell Scientific, 1990
14. Mukawa K, Nakamura T, Nakano G, Nagamachi Y: Histopathogenesis of intestinal metaplasia: minute lesion of intestinal metaplasia in ulcerated stomach. J Clin Pathol 40:13-18, 1987
15. Peterson J, Borch K, Franzen LE: Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol 37:262-266, 2002
16. Rembiasz K, Urban A, Szczudrawa J, Bobrzynski A, Oszacki J: Wystepowanie i topografia metaplazji blony sluzowej zoladka u chorych na wrzod zoladka, wrzod dwunastnicy i w grupie kontrolnej. Pat Pol 35:287-308, 1984
17. Sipponen P, Seppala K, Varis K, Hjelt L, Ihamaki T, Kekki M, Siurala M: Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Path Microbiol Scand 88:217-224, 1980
18. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 52:6735-6740, 1992
19. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M: Gastric cancer risk in chronic atrophic gastritis. Statistical calculations of cross-sectional data. Int J Cancer 35:173-177, 1985
20. Sipponen P: Intestinal metaplasia and gastric carcinoma. Ann Clin Res 13:139-143, 1981
21. Tytgat GNJ: Review article: practical management issues for the Helicobacter pylori-infected patient at risk of gastric cancer. Aliment Pharmacol Ther 12:123-128, 1998
22. 13C-urea in the diagnosis of Helicobacter pylori infection. J Physiol Pharmacol 47:545-553, 1996
23. Kuipers EJ: Review article: Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 12:25-36, 1998
24. Peterson WL: Review article: Helicobacter pylori and gastric adenocarcinoma. Aliment Pharmacol Ther 16:40-46, 2002
25. Sipponen P, Hyvarinen H, Seppala K, Blaser MJ: Review article: pathogenesis of the transformation from gastritis to malignancy. Aliment Pharmacol Ther 12:61-71, 1998
26. Oksanen A, Sipponen P, Karttunen R, Miettinen A, Veijola L, Sarna S, Rautelin H: Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 46(4):460-463, 2000
27. Oksanen A, Sipponen P, Miettinen A, Sarna S, Rautelin H: Evaluation of blood tests for predicting normal gastric mucosa. Gut 45(3S): 126-127, 1999
28. Sipponen P, Samloff IM, Saukkonen M, Varis K: Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy. Gut 26:1179-1182, 1985
29. Sipponen P, Linnala A, Sande N, Vaananen H, Rasmussen M, Tunturi-Hihnala H, Sotka M, Turunen M, Sandstrom R, Heiskanen I, Suovaniemi O, Harkonen M: Serum levels of gastrin-17 pepsinogen I and H. pylori antibodies in nonendoscopic diagnosis of atrophic gastritis. Gut 49:1718, 2001
30. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, pepsinogen II and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 83:204-209, 1982
31. Knight T, Wyatt J, Wilson A, Greaved S, Newell D, Hengels K, Corlett M, Webb P, Forman D, Elder J: H. pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in a high risk group. Br J Cancer 73:819-824, 1996
32. Matsumoto K, Konishi N, Ohshima M, Hiasa Y, Kimura E, Samori T: Association between Helicobacter pylori infection and serum pepsinogen concentration in gastroduodenal diseases. J Clin Pathol 49:1005-1008, 1996
33. Plebani M, Basso D, Scrigner M, Toma A, Di Mario E, Dal Bo N, Samloff IM: Serum pepsinogen C a useful marker of H. pylori eradication? J Clin Lab Anal 10:1-6, 1996
34. Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR, Ooms EC, Kreuning J, Kostense PJ, Eriksson AW: Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 59:952-958, 1987
35. Sipponen P, Samloff IM, Saukkonen M, Varis K: Serum pepsinogen I and II and gastric mucosal histology after parietal gastrectomy. Gut 26:1179-1182, 1985
36. Kitahara F, Kobyashi K, Sato T, Kojima Y, Araki T, Fujimo MA: Accracy of screening of gastric cancer using serum pepsinogen concentrations. Gut 44:693-697, 1999.
37. Konturek SJ, Konturek PC, Bielanski W, Lorens K, Sito E, Konturek JW, Kwiecien S, Bobrzynski A, Pawlik T, Karcz D, Areny H: Case presentation of gastrinoma combined wih carcinoidband with longest survival record - Zollinger-Ellison syndrome. Med Sci Monit 8:CS43-59, 2002
38. Konturek PC, Konturek SJ, Bielanski W, Kania J, Zuchowicy M, Harwich A, Rehfeld JF, Hahn EG: Influence of COX+2 inhibition bz rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis related proteins in gastric cancer patients. Dig Dis Sci 48:2005-2017, 2003
39. Waldum HE, Fossmark, Bakke I, Martinsen TC, Qvigstad G: Hypergastrinemia in animals and man. Causes and consequences. Scand J Gastroenterol 39:505-509, 2004
40. Varis K, Kekki, N, Harkonen, Sipponen P, Samloff IN: Serum pepsinogen and serum gastrin in screening of atrophic gastritis and high risk of gastric cancer. Scand J Gastroenterol 186:117-123, 1991
41. Bechi P, Bacci S, Cianchi F, Amarosi A, Nesi G, Dei R, Romagnoli P: Impairement of gastric secretion modulation in duodenal ulcer and in long-term PPI treatment. Quantitative morphologic findings and pathophysiologic implications. Dig Dis Sci 46:1952-1959, 2001